Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PMCK BhdXKLS:0363 -2.38%21 EV-to-EBITDA is 7.63 as of Aug. 23, 2026, which is 18% below its 10-year median of 9.28. GuruFocus rates XKLS:0363 with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 515 Healthcare Providers & Services companies, PMCK Bhd ranks better than 68.16% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PMCK Bhd's enterprise value is RM169.78 Mil.
PMCK Bhd's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was RM22.25 Mil. Therefore, PMCK Bhd's EV-to-EBITDA for today is 7.63.
The historical rank and industry rank for PMCK Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:0363'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.9 Med: 9.28 Max: 72.16
Current: 7.63
During the past 5 years, the highest EV-to-EBITDA of PMCK Bhd was 72.16. The lowest was 6.90. And the median was 9.28.
XKLS:0363's EV-to-EBITDA is ranked better than 68.16% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.65
vs XKLS:0363: 7.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PMCK Bhd's share price for today is RM0.205.
PMCK Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.093.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for PMCK Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0363 vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PMCK Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMCK Bhd EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PMCK Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PMCK Bhd's EV-to-EBITDA falls into.
PMCK Bhd's current Enterprise Value is RM169.78 Mil.
PMCK Bhd's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM22.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMCK Bhd (XKLS:0363) has a EV-to-EBITDA of 7.63 as of Aug. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PMCK Bhd. This is 18% below median its historical median of 9.28. Over the past decade, PMCK Bhd's EV-to-EBITDA has ranged from 6.90 to 72.16. According to the industry distribution chart, PMCK Bhd ranks #164 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 31.8%.
Is PMCK Bhd's EV-to-EBITDA too high?
PMCK Bhd's current EV-to-EBITDA of 7.63 is 18% below median its 10-year median of 9.28. Over the past 10 years, this metric has ranged from a low of 6.90 to a high of 72.16. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.65. PMCK Bhd's value of 7.63 is 28.4% below this industry median. Based on the distribution chart, PMCK Bhd ranks #164 out of 515 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PMCK Bhd has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PMCK Bhd's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PMCK Bhd ranks #164 out of 515 companies for EV-to-EBITDA. This puts PMCK Bhd in the upper half of its industry. The industry median EV-to-EBITDA is 10.65. PMCK Bhd's value of 7.63 is 28.4% below this benchmark. Historically, PMCK Bhd's own EV-to-EBITDA has ranged from 6.90 to 72.16 over the past decade. While the company's 10-year median is 9.28 vs. the industry median of 10.65, PMCK Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.65, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMCK Bhd's current EV-to-EBITDA of 7.63 is 28.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PMCK Bhd. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMCK Bhd's current EV-to-EBITDA is 7.63, which is 18% below median its own 10-year median of 9.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMCK Bhd stock overvalued right now?
PMCK Bhd (XKLS:0363) has a current EV-to-EBITDA of 7.63. The current EV-to-EBITDA is 7.63, which is 18% below median its 10-year median of 9.28 and 28.4% below the Healthcare Providers & Services industry median of 10.65. PMCK Bhd's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PMCK Bhd (XKLS:0363), the current EV-to-EBITDA is 7.63 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMCK Bhd is a healthcare service provider in Malaysia operating through its Putra Medical Centre. The company focuses on specialist consultant services across various medical fields such as anaesthesiology, cardiology, dermatology, emergency medicine, internal medicine, ophthalmology, orthopaedics, paediatrics, radiology, and surgery among others. Also, it provides healthcare support services including facility management, ward services, clinical support, medication sales, and nursing care, as well as general dental, polyclinic, and medical laboratory services. PMCK generates revenue majorly from these healthcare services and has a broad panel coverage with multiple insurance companies and government agencies facilitating patient access.
21GF Score
Get the complete analysis for XKLS:0363
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0363 has been successfully added to your 
